Covance, a global contract research organization, worked on all of the top 50 best-selling drugs available today through its full spectrum of nonclinical, clinical and commercialization services.
Covance is dedicated to advancing healthcare and delivering Solutions Made Real®
With precision delivery of the largest volume of drug development data on the planet, we can help you identify new approaches and anticipate tomorrow’s challenges. Learn more about our history and services.
Clinical Trial Monitoring
Xcellerate® CRA Dashboard: The Future of Monitoring
Learn how this award winning novel solution is improving site quality and performance through monitoring efficiency.
Real-Time Data. Real-World Impact.
Combining four unique data sets with our therapeutic and functional expertise, Covance can impact protocol design and feasibility, optimal site selection, and patient recruitment.
Covance wins Best Technological Development in Clinical Trials - Clinical Sponsor-focused at the 14th Annual Scrip Awards
Covance has developed the Xcellerate CRA Dashboard to help clinical research associates access to near real-time site-level data anywhere, at any time. The mobile and web-enabled application gives CRAs enhanced visibility to site performance data, reducing the complexity of site monitoring and enabling more effective management.
End-to-end drug & diagnostic development support for a new immuno-oncology agent
Find out how Covance/LabCorp helped a prominent pharmaceutical company enable a faster, more effective launch of their immuno-oncology drug.
Join us at Scope 2019 on February 18 - 21 in Orlando, Florida and discover how Xcellerate® Informatics can help you deliver better study outcomes.
Solutions to minimize risk and optimize your trial designs
Discover how our innovation, commitment and expertise can accelerate your complex immuno-oncology drug development
Analytical methods for bioanalysis
Check out our recently updated nonproprietary assay list featuring more than 330 compounds.
Immuno-oncology education center
Learn about the latest advances in immuno-oncology. Download webinars, white papers, case studies and blogs.
Access the latest in scientific and patient centric solutions for your Rare Disease and Orphan Drug Development Program
Enhancing Study Design with a Real World Evidence Tool
Real World Evidence (RWE) has the potential to transform our industry, but there are a number of challenges when it comes to planning a study and execution. Learn about a powerful new tool that can help improve your RWE study design and register for our webinar today.
Data, Risk and Technology in Clinical Research
Reduce cost, increase efficiency, and mitigate risk in the clinical trial landscape.
Xcellerate® Informatics Suite
Successful clinical trials begin and end with the RIGHT data. Uncover new possibilities for your clinical trials with Xcellerate®, a fully integrated informatics platform. ONE comprehensive platform. UNPARALLELED RESULTS.
Bioanalysis Education Center: Covance leads the way in bioanalytical capabilities and solutions, igniting innovation with exceptional science and timely answers.
Access the latest scientific posters, list of non-proprietary/generic assays, publications and info sheets.
Lessons Learned from Completed Trials in NAFLD/NASH, PBC and PSC
February 13, 2019 | 10 a.m. EST
Central Laboratory Services (ELMS)
Is your team more focused on managing referral labs than actual science?
As clinical trials become more complex, they require more specialty testing. There's a way to support this requirement without wasting valuable in-house resources on lab management.
Tour the Interactive, Virtual Safety Facility
See for yourself, through the magic of virtual technology, why more than 90% of the clinical studies placed in our Greenfield, Indiana, (USA) facility serve nimble and progressive biopharma ventures in this interactive tour. Learn more.
Rare Disease and Orphan Drugs: accelerate complex studies globally
A range of individual approaches can be integrated to accelerate your progress of complex rare disease studies across the world. Learn how to address key development challenges.